Pharmacovigilance of antiretroviral dolutegravir in the state of Paraná

The aim of this study was to investigate adverse reactions to Dolutegravir, a drug recently made available by the Unified Health System (SUS) for treating HIV infections. The frequency, severity and sex distribution of adverse reactions to Dolutegravir were identified over the first 18 months of it...

Full description

Bibliographic Details
Main Authors: Bárbara Thaís Poliselo de Sá, Frederico Alves Dias, Flavia Helen Correia, Doroteia Aparecida Höfelmann, Yanna Dantas Rattmann
Format: Article
Language:English
Published: Universidade Estadual de Maringá 2022-01-01
Series:Acta Scientiarum. Health Sciences
Subjects:
Online Access:https://periodicos.uem.br/ojs/index.php/ActaSciHealthSci/article/view/53630